Product Name |
MF |
CAS |
Details |
CARBAMAZEPINE EP |
C15H12N2O |
298-46-4 |
|
6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole Hydrochloride |
C12H14ClFN2O |
84163-13-3 |
|
N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride. |
C20H23ClN2O2 |
482577-59-3 |
|
LEFLUNOMIDE IH |
C12H9F3N2O2 |
75706-12-6 |
|
ACETAMINOPHEN USP |
C8H9NO2 |
103-90-2 |
|
PARACETAMOL IP |
C8H9NO2 |
103-90-2 |
|
AZITHROMYCIN IP |
C38H72N2O12 |
83905-01-5 |
|
GLIBENCLAMIDE IP |
C23H28ClN3O5S |
10238-21-8 |
|
GUAIFENESIN IP |
C10H14O4 |
93-14-1 |
|
(2,4-Difluorophenyl)-4-piperidylmethanone Oxime Hydrochloride |
C12H15ClF2N2O |
135634-18-3 |
|
MELOXICAM BP |
C14H13N3O4S2 |
71125-38-7 |
|
CLARITHROMYCIN IH |
C38H69NO13 |
81103-11-9 |
|
DICYCLOMINE HCl IP |
C19H36ClNO2 |
67-92-5 |
|
Butylated Hydroxyanisole |
C11H16O2 |
25013-16-5 |
|
3-Pyridylacetic Acid Hydrochloride |
C7H8ClNO2 |
6419-36-9 |
|
1-(3-Chloropropyl)-1,3-dihydro-2H-benzimidazol-2-one |
C10H11ClN2O |
62780-89-6 |
|
Oxoacetic acid monohydrate |
C2H4O4 |
563-96-2 |
|
(E)-1-Propene-1,2,3-tricarboxylic Acid |
C6H6O6 |
4023-65-8 |
|
4'-Bromomethyl-2-cyanobiphenyl |
C14H10BrN |
114772-54-2 |
|
(3R)-1-azabicyclo[2.2.2]-3-ol |
C7H13NO |
25333-42-0 |
|
METHOTREXATE IH |
C20H22N8O5 |
59-05-2 |
|
(S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl chloride |
C10H8ClF3O2 |
20445-33-4 |
|
(R)-(+)-1-(1-Naphthyl)ethylamine |
C12H13N |
3886-70-2 |
|
BROMHEXINE HYDROCHLORIDE IP |
C14H21Br2ClN2 |
611-75-6 |
|
3H-1,2,3-Triazolo[4,5-b]pyridin-3-ol |
C5H4N4O |
39968-33-7 |
|
(R)-2,2,2-trifluoro-1-phenylethanamine |
C8H8F3N |
22038-85-3 |
|
Methylmaleic Acid |
C5H6O4 |
498-23-7 |
|
[Methyl(-)-(R)-(o-Chlorophenyl)-6,7-dihydrothieno[3,2,c]pyridine-5-(4H)acetate hydrogen sulphate] |
C16H18ClNO6S2 |
120202-71-3 |
|
ATENOLOL IP |
C14H22N2O3 |
29122-68-7 |
|
TRIMETAZIDINE HYDROCHLORIDE IH |
C14H22N2O3 |
5011-34-7 |
|
AMLODIPINE BESYLATE IP |
C26H31ClN2O8S |
111470-99-6 |
|
AMLODIPINE BESYLATE IP |
C26H31ClN2O8S |
111470-99-6 |
|
6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole |
C12H13FN2O |
84163-77-9 |
|
(S)-2,2,2-trifluoro-1-phenylethanamine |
C8H8F3N |
63197-94-8 |
|
AMBROXOL HCl IP |
C13H19Br2ClN2O |
23828-92-4 |
|
(S)-N-benzyl-1-(1-naphthyl)ethylamine hydrochloride |
C12H13N |
10420-89-0 |
|
4-Oxo-1-piperidinecarboxylic Acid Ethyl Ester |
C8H13NO3 |
29976-53-2 |
|
IBUPROFEN IP |
C13H18O2 |
15687-27-1 |
|
IBUPROFEN EP |
C13H18O2 |
15687-27-1 |
|
3-[3-(Trifluoromethyl)phenyl]propan-1-ol |
C10H11F3O |
78573-45-2 |
|
FOLIC ACID IP |
C19H19N7O6 |
59-30-3 |
|
(R)-N-benzyl-1-(1-naphthyl)ethylamine hydrochloride |
C19H20ClN |
163831-65-0 |
|
(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine |
C7H14N2 |
147459-51-6 |
|
1,1-Cyclohexanediacetic acid monoamide |
C10H17NO3 |
99189-60-3 |
|
DICLOFENAC SODIUM IP |
C14H10Cl2NNaO2 |
15307-79-6 |
|
RANITIDINE HYDROCHLORIDE IH |
C13H22N4O3S |
66357-35-5 |
|
SALBUTAMOL SULPHATE IP |
C13H23NO7S |
51022-70-9 |
|
SALBUTAMOL SULFATE BP |
C13H23NO7S |
51022-70-9 |
|
DEXTROMETHORPHAN HBr IP |
C18H28BrNO2 |
6700-34-1 |
|
CETIRIZINE HYDROCHLORIDE IP |
C21H26Cl2N2O3 |
83881-52-1 |
|
(S)-N-benzyl-1-phenylethanamine |
C15H17N |
17480-69-2 |
|
ALBENDAZOLE IP |
C12H15N3O2S |
54965-21-8 |
|
(R) Ethyl nipecotate |
C8H15NO2 |
25137-01-3 |
|
DOXEPIN HYDROCHLORIDE EP |
C19H22ClNO |
1229-29-4 |
|
[Methyl(?)-(o-Chlorophenyl)-4,5-dihydrothieno[2,3,c]pyridine-6(7H)Acetate hydrogen sulphate |
C16H18ClNO6S2 |
135046-48-9 |
|
3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido-(1,2a)-pyrimidin-4-one |
C11H15ClN2O |
63234-80-0 |
|
(S) Ethyl nipecotate |
C8H15NO2 |
37675-18-6 |
|
ACECLOFENAC IP |
C16H13Cl2NO4 |
89796-99-6 |
|
(S)-2,2,2-trifluoro-1-(naphthalen-1-yl)ethanamine |
C12H10F3N |
1213116-97-2 |
|
PROMETHAZINE HCI IP |
C17H21ClN2S |
58-33-3 |
|
[1-Hydroxy-2-(3-pyridinyl)ethylidene]bisphosphonic Acid |
C7H11NO7P2 |
105462-24-6 |
|
LEVOFLOXACIN HEMIHYDRATE IH |
C18H22FN3O5 |
138199-71-0 |
|
(R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl chloride |
C10H8ClF3O2 |
39637-99-5 |
|
(R)-(2,2-dimethyl-1,3-dioxolan-4-yl)methanol |
C6H12O3 |
14347-78-5 |
|
DIPHENHYDRAMINE HCl IP |
C17H21NO |
58-73-1 |
|
METFORMIN HCl IP |
C4H12ClN5 |
1115-70-4 |
|
1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
C15H15N |
22990-19-8 |
|
(S)-6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid |
C10H9FO3 |
129101-36-6 |
|
L-Valine Methyl Ester Hydrochloride |
C6H13NO2.ClH |
6306-52-1 |
|
[(+)-(S)-(o-Chlorophenyl)-6,7-dihydrothieno[3,2,c]pyridine-5-(4H)-aceticacid] |
C15H14ClNO2S |
144457-28-3 |
|
AMOXICILLIN TRIHYDRATE IP |
C16H21N3O6S |
61336-70-7 |
|
PHENYLEPHRINE HCl USP |
C9H13NO2.ClH |
61-76-7 |
|
1,1-Cyclohexanediacetic acid |
C10H16O4 |
4355-11-7 |
|
OFLOXACIN IP |
C18H20FN3O4 |
82419-36-1 |
|
SODIUM PROPYLPARABEN IH |
C10H13NaO3 |
35285-69-9 |
|
CIPROFLOXACIN HCl IP |
C17H18FN3O3 |
85721-33-1 |
|
Cefuroxime acid |
C16H16N4O8S |
55268-75-2 |
|
Mannitol In House |
C6H14O6 |
69-65-8 |
|
(R)-6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid |
C10H9FO3 |
129101-37-7 |
|
NAPROXEN SODIUM IP |
C14H13O3.Na |
26159-34-2 |
|
Moxifloxacin In House |
C21H24FN3O4 |
354812-41-2 |
|
(S)-2(2,2-dimethyl-l,3-dioxolan-4-yl)methanol |
C6H12O3 |
22323-82-6 |
|
SULFADOXINE USP |
C12H14N4O4S |
2447-57-6 |
|
(R)-N-benzyl-1-phenylethanamine |
C15H17N |
38235-77-7 |
|
2-Propene-1,2-dicarboxylic Acid |
C5H6O4 |
97-65-4 |
|
DOMPERIDONE IP |
C22H24ClN5O2 |
57808-66-9 |
|
(4aR,7aR)-octahydro-1H-pyrrolo[3,4-b]pyridine |
C7H14N2 |
151213-40-0 |
|
Rosuvastatin Calcium In House |
C22H28FN3O6S |
287714-41-4 |
|
LEVOCETIRIZINE HYDROCHLORIDE IP |
C21H27Cl3N2O3 |
130018-87-0 |
|
CHLORPHENIRAMINE MALEATE IP |
C20H23ClN2O4 |
113-92-8 |
|
4-(2,4-Difluorobenzoyl)-piperidine HCl |
C12H14ClF2NO |
106266-04-0 |
|
1-Methyl-4-piperidone |
C6H11NO |
1445-73-4 |
|
2-(N,N-Dimethylaminomethyl)cyclohexanone |
C9H17NO |
15409-60-6 |
|
(2R)-1,2-Propanediol,3-amino, hydrochloride |
|
|
|
(R)-2,2,2-trifluoro-1-(naphthalen-1-yl)ethanamine |
|
|
|
(R)-N-benzyl-2,2,2-trifluoro-1-phenylethanamine |
|
|
|
(S)-N-benzyl-2,2,2-trifluoro-1-phenylethanamine |
|
|
|
(2S)-1,2-Propanediol,3-amino-, hydrochloride |
|
|
|